SUNY, NYU, Galderma Sue Indian Generics Pharma Lupin for Allegedly Infringing Rosacea Rx IP

The suit is the second filed by the plaintiffs this year against a generic drug manufacturer for allegedly infringing patents protecting Galderma's rosacea treatment Oracea by filing an ANDA for a generic version of the drug.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.